See more : Bright Scholar Education Holdings Limited (BEDU) Income Statement Analysis – Financial Results
Complete financial analysis of Larkspur Health Acquisition Corp. (LSPRW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Larkspur Health Acquisition Corp., a leading company in the Shell Companies industry within the Financial Services sector.
- ENGIE SA (ENGIY) Income Statement Analysis – Financial Results
- Ross Stores Inc (RSO.DE) Income Statement Analysis – Financial Results
- Telo Genomics Corp. (TDSGF) Income Statement Analysis – Financial Results
- Ellington Financial Inc. (0A26.L) Income Statement Analysis – Financial Results
- Lagardere SA (MMB.SW) Income Statement Analysis – Financial Results
Larkspur Health Acquisition Corp. (LSPRW)
Industry: Shell Companies
Sector: Financial Services
About Larkspur Health Acquisition Corp.
Larkspur Health Acquisition Corp., a blank check company, focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on business in the biotechnology sector in the United States. The company was incorporated in 2021 and is based in Bridgewater, New Jersey.
Metric | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 10.40K | 10.40K | 10.40K | 10.40K |
Gross Profit | -10.40K | -10.40K | -10.40K | -10.40K |
Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
Research & Development | 3.21M | 5.41M | 2.12M | 6.47M |
General & Administrative | 11.21B | 7.61M | 5.58M | 5.36M |
Selling & Marketing | -11.20B | 0.00 | 0.00 | 0.00 |
SG&A | 11.20M | 7.61M | 5.58M | 5.36M |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 14.41M | 13.01M | 7.70M | 11.83M |
Cost & Expenses | 14.42M | 13.01M | 7.70M | 11.83M |
Interest Income | 0.00 | 427.54 | 821.37 | 516.45 |
Interest Expense | -457.00K | 427.54K | 821.37K | 516.45K |
Depreciation & Amortization | 10.40K | 10.40K | 10.40K | 10.40K |
EBITDA | -107.74M | -11.67M | -7.25M | -12.16M |
EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Income | -14.42M | -13.01M | -7.70M | -11.83M |
Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | -93.33M | -2.37M | -379.79K | -850.11K |
Income Before Tax | -107.75M | -14.05M | -8.08M | -12.68M |
Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | -9.46M | 745.05M | 821.37K | 516.45K |
Net Income | -98.30M | -759.10M | -8.91M | -13.20M |
Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
EPS | -1.09K | -930.25 | -173.66 | -272.45 |
EPS Diluted | -1.09K | -930.25 | -173.66 | -272.45 |
Weighted Avg Shares Out | 97.50K | 25.95K | 46.55K | 46.55K |
Weighted Avg Shares Out (Dil) | 97.50K | 25.95K | 46.55K | 46.55K |
Source: https://incomestatements.info
Category: Stock Reports